These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 627753)

  • 1. Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity.
    Levy M; Wexler MJ
    J Lab Clin Med; 1978 Mar; 91(3):520-36. PubMed ID: 627753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium retention and ascites formation in dogs with experimental portal cirrhosis.
    Levy M
    Am J Physiol; 1977 Dec; 233(6):F572-85. PubMed ID: 596455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dogs with experimental cirrhosis of the liver but without intrahepatic hypertension do not retain sodium or form ascites.
    Unikowsky B; Wexler MJ; Levy M
    J Clin Invest; 1983 Nov; 72(5):1594-604. PubMed ID: 6630520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased blood flow through the portal system in cirrhotic rats.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of portal hypertension.
    Bosch J; Pizcueta P; Feu F; Fernández M; García-Pagán JC
    Gastroenterol Clin North Am; 1992 Mar; 21(1):1-14. PubMed ID: 1568769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W; Liu P; Blendis L; Wong F
    Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].
    Ortiz MC; Fortepiani LA; Martínez-Salgado C; Eleno N; Atucha NM; López-Novoa JM; García-Estañ J
    Nefrologia; 2001; 21(6):556-64. PubMed ID: 11881425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Natural course and physiopathology of ascites in the cirrhotic patient].
    Bernardi M; Colantoni A; Caraceni P; Sica G; Trevisani F
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():30S-38S. PubMed ID: 9004818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic denervation alters first-phase urinary sodium excretion in dogs with cirrhosis.
    Levy M; Wexler MJ
    Am J Physiol; 1987 Oct; 253(4 Pt 2):F664-71. PubMed ID: 3661718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary sodium retention in chronic liver disease: a summary.
    Levy M
    Isr J Med Sci; 1986 Feb; 22(2):67-9. PubMed ID: 3949490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic peptide: renal effects in cirrhosis of the liver.
    Levy M
    Semin Nephrol; 1997 Nov; 17(6):520-9. PubMed ID: 9353863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The renin-angiotensin-aldosterone system in liver cirrhosis].
    Giudici Cipriani A; Folco U; Colombo P; Menardo G; Cattana A; Barbetti V; Rembado R; Marenco G
    Minerva Med; 1990; 81(1-2):45-53. PubMed ID: 2314615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascites kinetics in cirrhosis: effects of rapid volume expansion and diuretic administration.
    Rector WG
    J Lab Clin Med; 1988 Feb; 111(2):166-72. PubMed ID: 3339270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of ascites formation.
    Dudley FJ
    Gastroenterol Clin North Am; 1992 Mar; 21(1):215-35. PubMed ID: 1568774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis.
    Wong F; Liu P; Lilly L; Bomzon A; Blendis L
    Clin Sci (Lond); 1999 Sep; 97(3):259-67. PubMed ID: 10464050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascites in liver diseases.
    Gentilini P; Laffi G
    Ann Ital Med Int; 1991; 6(1 Pt 2):148-55. PubMed ID: 1742150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathophysiology of portal hypertension and mechanisms of sodium and water retention in cirrhosis].
    Garini G; Delsante M; Iannuzzella F
    Recenti Prog Med; 2011 Mar; 102(3):134-40. PubMed ID: 21572486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of ascites formation in cirrhosis of the liver.
    Gerbes AL
    Hepatogastroenterology; 1991 Oct; 38(5):360-4. PubMed ID: 1765351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.